
CrossGen has been in financial turmoil for much of this year. The Comics Journal takes an in-depth look at the company's status, including the emergence of a new corporate entity, designed to lure investors to the exploitation of their concepts as movies and TV shows.
According to the write up, much of CrossGen's strategy relies on the success of their current comic-to-film front runner, "Way of the Rat". However, the option on "Rat" expires next February and the option on the next furthest project, "Route 666" is up in August.
More...